FULLER GILBERT A 4
4 · USANA HEALTH SCIENCES INC · Filed Jan 26, 2026
Research Summary
AI-generated summary of this filing
USANA (USNA) Director Gilbert Fuller Converts 1,058 RSUs; Shares Withheld
What Happened
- Gilbert A. Fuller, a director of USANA Health Sciences (USNA), had 1,058 restricted stock units (RSUs) convert into 1,058 shares on January 22, 2026. The filing shows an acquisition via derivative conversion and a simultaneous disposition of the same 1,058 shares at $0.00, indicating the shares were withheld to satisfy tax withholding obligations. No cash proceeds were reported.
Key Details
- Transaction date: 2026-01-22 (reported on Form 4 filed 2026-01-26; filing appears timely).
- Transaction type/code: M — exercise/conversion of derivative (RSU conversion to shares).
- Shares converted: 1,058 RSUs → 1,058 common shares.
- Shares disposed/withheld: 1,058 shares at $0.00 (used to satisfy tax withholding).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes: F1 clarifies each RSU equals one share; F2 shows these RSUs vest on a schedule including Jan 22, 2026 (25% vesting on each listed date).
Context
- This was a scheduled RSU vesting and conversion, not an open-market purchase or sale. The withheld shares are a routine tax-withholding action and do not necessarily signal a buy/sell sentiment by the insider.
- For retail investors, conversions where shares are immediately withheld for taxes are common and typically administrative rather than predictive of company performance.
Insider Transaction Report
Form 4
FULLER GILBERT A
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-22+1,058→ 1,058 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-01-22−1,058→ 1,057 total→ Common Stock (1,058 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- [F2]Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Signature
/s/ Joshua Foukas, Attorney-in-Fact|2026-01-26